Francesco Maria Lavino


Francesco has over 20 years of pharma and biotech experience in strategic and operational roles in US, Europe and Emerging Markets. He served as Chief Commercial Officer at Nabriva Therapeutics from July 2017, where he led the commercial organization buildout and the launch of Xenleta, a first-in-class new antibiotic treatment. Prior to Nabriva,...

Roles at F2G

  • CEO

    April, 2021 - present

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at F2G

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.